Please login to the form below
hypoglycaemia
This page shows the latest hypoglycaemia news and features for those working in and with pharma, biotech and healthcare.
Sanofi reveals positive phase 3 results for long-acting insulin Toujeo
In addition, the percentage of participants who experienced severe hypoglycaemia and who experienced high blood sugar (hyperglycaemic) events were similar. ... The number of patients experiencing severe hypoglycaemia and who experienced hyperglycaemia
Latest news
-
Vertex eyes type 1 diabetes cure with biotech acquisition
The biotech has advanced the ability to produce large quantities of functional human pancreatic beta cells that restore insulin production and ameliorate hypoglycaemia in animal tests.
-
Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease
increased risk of side effects like hypoglycaemia or lactic acidosis.
-
Novo spends $800m to buy biotech and 'glucose responsive insulin' tech
Combining this technology with Novo Nordisk’s insulin to create GRIs would ultimately help further its goal of eliminating the risk of hypoglycaemia, the main risk associated with insulin therapy. ... have the potential to lead to the development of
-
FDA starts review of Sanofi’s oral type 1 diabetes drug
The results suggest adding the drug to insulin therapy can improve glucose control as measured by haemoglobin A1c levels, with a reduced risk of potentially dangerous low blood sugar levels (hypoglycaemia).
-
Novo says real-world data backs its insulin switching
Rates of overall hypoglycaemia were also significantly lower after switching to Tresiba, falling 85% in type 1 and 92% in type 2 patients at six months. ... compare the two drugs on not only glucose control and hypoglycaemia but also cardiovascular
More from news
Approximately 2 fully matching, plus 86 partially matching documents found.
Latest Intelligence
-
Case study: The KiDS project in India and Brazil
For example, poorly controlled levels of blood sugar can result in frightening and potentially damaging hypoglycaemia and hyperglycaemia.
-
Interview: Peter Meeus, Novo Nordisk
end of last year and has demonstrated it is as effective in reducing blood glucose levels as is its rival Lantus from Sanofi, yet carries less risk of hypoglycaemia. ... In addition, Meeus highlighted a need to raise awareness among the healthcare
-
Interview: Pierre Chancel, Sanofi Diabetes
2 diabetes further reduce HbA1c, with the benefit of weight loss and limited risk of hypoglycaemia.”.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
How technology is shaping patient education
The simulation showed the high impact of mild hypoglycaemia (low blood sugar) on a patient; it made the viewer ‘feel’ the symptoms of hypoglycaemia in various scenarios through a typical day
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Senior Medical Writer
-
Competitive Salary
-
Medical Editor
-
Competitive Salary
-
Senior Account Executive
-
Competitive Salary
-
Account Management
-
Competitive Salary Offered
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Publications Director
-
Competitive Salary
-
Account Manager
-
Competitive Salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Associate Account Director
-
Competitive Salary
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- GSK’s revenue drops by 18% in Q1 as performance pressures mount
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
- Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
- Live Webinar: Blockchain in Healthcare: Predictions for the Post-COVID World
- Live Webinar: Digital Health for Improving Care in Disadvantaged Populations
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Illingworth Research Group wins ‘prestigious’ Queen’s Award
- Working in true partnership in a time of change
- Live Webinar: The Future of Digital Pills
- Total COVID-19 vaccine spending to reach $157bn by 2025, says report
- NICE sets out plans for ‘ambitious’ five-year strategy
- Pfizer CEO says oral COVID-19 pill could be ready by the end of the year
- PMEA 2021 has officially launched – with a new online entry system
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
- Deep 6 AI: the smart software breathing new life into clinical trials
- Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
- COVID-proof: How Teams are Creating Launch Intensity thru Adversity
- Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
